TPX2 and pancreatic neoplasm: 4 implanted TPX2 siRNA-treated pancreatic cancer cells subcutaneously in nude mice and found that the cells treated with TPX2 siRNA showed a dramatic reduction in tumor growth compared to those treated with the vehicle control or a nonsilencing siRNA.